tiprankstipranks
Trending News
More News >
International Stem Cell (ISCO)
OTHER OTC:ISCO
US Market

International Stem Cell (ISCO) Income Statement

Compare
43 Followers

International Stem Cell Income Statement

Last quarter (Q3 2025), International Stem Cell's total revenue was $2.37M, a decrease of -3.15% from the same quarter last year. In Q3, International Stem Cell's net income was $57.00K. See International Stem Cell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.09M$ 7.79M$ 8.18M$ 7.18M$ 7.13M
Gross Profit
$ 5.32M$ 4.61M$ 4.91M$ 4.24M$ 4.35M
Operating Expenses
$ 5.39M$ 5.27M$ 5.09M$ 6.16M$ 7.17M
Depreciation and Amortization
$ 206.00K$ 194.00K$ 359.00K$ 551.00K$ 253.00K
EBITDA
$ 142.00K$ 202.00K$ 22.00K$ -220.00K$ -2.36M
Operating Income
$ -68.00K$ -663.00K$ -196.00K$ -1.92M$ -2.82M
Other Income/Expenses
$ -141.00K$ 532.00K$ -148.00K$ 1.02M$ 94.00K
Pretax Income
$ -209.00K$ -131.00K$ -331.00K$ -899.00K$ -2.72M
Net Income
$ -209.00K$ -131.00K$ -466.00K$ -1.04M$ -2.84M
Per Share Metrics
Basic EPS
$ -0.03$ -0.02$ -0.06$ -0.13$ -0.38
Diluted EPS
$ -0.03$ -0.02$ -0.06$ -0.13$ -0.38
Weighted Average Shares Outstanding
8.00M 8.00M 8.00M 7.83M 7.54M
Weighted Average Shares Outstanding (Diluted)
8.00M 8.00M 8.00M 7.83M 7.54M
Currency in USD

International Stem Cell Earnings and Revenue History